Journal Article

Phosphoproteomic mapping reveals distinct signaling actions and activation of muscle protein synthesis by Isthmin-1

Zhao, Meng, Cuthbert, Nickeisha, Svensson, Katrin J, Bielczyk-Maczynska, Ewa, Paramasivam, Shrika, Nguyen, Quennie, Voilquin, Laetitia, Banhos Danneskiold-Samsøe, Niels, White, James P, Jiang, Zewen, Lee, David E, Ulicna, Livia, Van Rechem, Capucine

2022

Overview

The secreted protein isthmin-1 (Ism1) mitigates diabetes by increasing adipocyte and skeletal muscle glucose uptake by activating the PI3K-Akt pathway. However, while both Ism1 and insulin converge on these common targets, Ism1 has distinct cellular actions suggesting divergence in downstream intracellular signaling pathways. To understand the biological complexity of Ism1 signaling, we performed phosphoproteomic analysis after acute exposure, revealing overlapping and distinct pathways of Ism1 and insulin. We identify a 53% overlap between Ism1 and insulin signaling and Ism1-mediated phosphoproteome-wide alterations in ~450 proteins that are not shared with insulin. Interestingly, we find several unknown phosphorylation sites on proteins related to protein translation, mTOR pathway, and, unexpectedly, muscle function in the Ism1 signaling network. Physiologically, Ism1 ablation in mice results in altered proteostasis, including lower muscle protein levels under fed and fasted conditions, reduced amino acid incorporation into proteins, and reduced phosphorylation of the key protein synthesis effectors Akt and downstream mTORC1 targets. As metabolic disorders such as diabetes are associated with accelerated loss of skeletal muscle protein content, these studies define a non-canonical mechanism by which this antidiabetic circulating protein controls muscle biology. Cells need energy to survive and carry out their role in the body. They do this by breaking down molecules, like sugar, into substances that can fuel the creation of new compounds, like proteins or lipids. This process, known as metabolism, involves a series of interconnecting chemical reactions which are organized into pathways. Metabolic pathways contain proteins that catalyze each sequential reaction. Hormones can change the activity of these proteins by adding a chemical group called a phosphate. This reversible modification can majorly impact the metabolism of cells, resulting in changes to the body’s tissues. The hormone insulin, for instance, alters a well-known metabolic pathway that triggers skeletal muscle cells to produce more proteins, leading to stronger and larger muscles. In 2021, a group of scientists discovered a molecule made by fat cells, called Isthmin-1, also activates components in this pathway. Similar to insulin, Isthmin-1 encourages muscle and fat cells to take up sugar. However, it also prevents the liver from accumulating excess fat, suggesting Isthmin-1 may trigger a different cascade of molecules to insulin. To investigate this possibility, Zhao et al. – including some of the researchers involved in the 2021 study – exposed cells grown in the laboratory to Isthmin-1 or insulin and looked for phosphates on all their proteins. This revealed that only 53% of the proteins Isthmin-1 modifies are also altered by insulin. Of the proteins unique to Isthmin-1, several had known roles in making and maintaining proteins in muscle cells. To understand more about the role of this newly discovered pathway, Zhao et al. genetically engineered mice to lack the gene that codes for Isthmin-1. This decreased the size and strength of the mice’s muscle fibers and reduced the signals that normally lead to skeletal muscle growth. These findings suggest that Isthmin-1 regulates skeletal muscle size via a metabolic pathway that is slightly different to the one activated by insulin. Many metabolic disorders are associated with muscle loss, like diabetes, and this newly discovered network of proteins could further our understanding of how to prevent and treat these diseases.

• Publisher: eLife Sciences Publications Ltd,eLife Sciences Publications, Ltd
• Subject: 1-Phosphatidylinositol 3-kinase / AKT protein / Amino acids / Amino Acids - metabolism / Animals / Antidiabetics / Cell Biology / Diabetes / Diabetes mellitus / Genes / Glucose / Glucose - metabolism / Hypoglycemic Agents - metabolism / Insulin / Insulin - metabolism / Insulin resistance / Intercellular Signaling Peptides and Proteins - metabolism / Intracellular signalling / Kinases / Ligands / Mechanistic Target of Rapamycin Complex 1 - metabolism / Metabolic disorders / Metabolism / Mice / muscle / Muscle function / Muscle Proteins - metabolism / Muscle, Skeletal - metabolism / Musculoskeletal system / Ontology / Peptide mapping / Peptides / Phosphatidylinositol 3-Kinases - metabolism / Phosphorylation / Principal components analysis / Protein Biosynthesis / Protein synthesis / Proteins / proteomics / Proto-Oncogene Proteins c-akt - metabolism / Signal transduction / signaling / Skeletal muscle / TOR protein / TOR Serine-Threonine Kinases - metabolism